MedPath

DOXAPRAM HYDROCHLORIDE

DOPRAM INJECTION (DOXAPRAM HYDROCHLORIDE INJECTION, USP) 400 mg/20 mL (20 mg/mL) 20 mL VIAL BOXED

Approved
Approval ID

954859c0-a121-34d6-e053-2a95a90a1e19

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 22, 2020

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DOXAPRAM HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1404
Application NumberNDA014879
Product Classification
M
Marketing Category
C73594
G
Generic Name
DOXAPRAM HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 22, 2020
FDA Product Classification

INGREDIENTS (3)

BENZYL ALCOHOLInactive
Quantity: 9 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
DOXAPRAM HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: P5RU6UOQ5Y
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DOXAPRAM HYDROCHLORIDE - FDA Drug Approval Details